The FDA approved daily obesity pill orforglipron on April 1. Here is what its main placebo-controlled trial found, and what patients still do not know.
The 2025-2030 U.S. Dietary Guidelines put more weight on whole foods and less on added sugar and heavily processed foods. Here’s what changed.
A January 2026 federal update makes HPV-only screening the preferred option for many women 30 to 65 and adds self-collection as a choice.
An NIH-backed 20-year follow-up links one specific speed-training program—not all brain games—to fewer dementia diagnoses. Here’s what it means.
New U.S. guidance says women 65 and older should be screened for osteoporosis, and some younger postmenopausal women should be screened sooner.
A new trial found less clinically important bleeding with apixaban than rivaroxaban after a serious clot, but treatment changes still need a clinician.
Blood in the urine is not always cancer, but new research suggests delayed follow-up is common. Here’s what hematuria means and when prompt care matters.
FDA approved the first generic Flovent HFA, but access may still depend on strength, pharmacy supply, insurance coverage, and safe switching.
FDA-authorized medical AI is already common in scans and workflow tools. Here’s what authorization means, what it does not, and what patients should ask.
Some medical AI tools are FDA-regulated, but authorization is not a promise of equal accuracy in every clinic. Here’s what patients should ask.
A knee arthritis study points to real symptom relief with semaglutide, but Medicare access still depends on why it is prescribed and who qualifies.
New CDC data show seasonal allergies affect about 1 in 4 U.S. adults and 1 in 5 children. Here’s how to spot them, treat symptoms, and know when to get care.
As of April 2026, the federal nursing home staffing rule is no longer being phased in. Here’s what it would have required and what families should watch now.
ACA Marketplace coverage in 2026 may require more paperwork, closer plan shopping, and higher premiums for some after extra tax-credit savings ended on Dec. 31, 2025.
New U.S. polling shows many people already ask AI about symptoms and test results. Here’s where it can help, where it can mislead, and when to get human care.
Current U.S. pain guidance says arthritis care should usually start with non-opioid options, with treatment tailored to arthritis type and daily function.
A needle-free epinephrine nasal spray is now available for some patients at risk of anaphylaxis, but fast treatment, backup doses, and emergency follow-up still matter.
New federal ACA Marketplace rules for 2026 tighten some enrollment steps, though some provisions are on hold. Here’s what shoppers should do now.
Federal telehealth prescribing flexibility for ADHD stimulants continues through December 31, 2026. Here’s what changed, what did not, and where barriers remain.
CDC says the United States has reported 1,671 confirmed measles cases in 2026. Here’s what families should check before spring and summer travel.
CDC’s global measles notice means international travelers should check immunity early, not days before departure, and families may need a pre-trip vaccine visit.
Postpartum mental-health support is stretching across the full first year after birth, with longer Medicaid coverage, more screening chances, and a federal hotline.
End of content
End of content
